PEMBRI
Live / Registered — Registered (as of 30 Jun 2020)
What this means for you
Registered since 30 Jun 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79269430
- Registration number
- 6087843
- Mark type
- Stylized text
- Filed
- 20 Aug 2019
- Published for opposition
- 14 Apr 2020
- Registered
- 30 Jun 2020
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma, all the foregoing specifically excluding antibiotic preparations and substances
Owner
- Novartis AG, CH
- Novartis AG, CH
- Novartis AG, CH
Prosecution history
- 30 Jun 2025 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 14 Nov 2020 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 28 Oct 2020 — FINAL DISPOSITION NOTICE SENT TO IB
- 28 Oct 2020 — FINAL DISPOSITION PROCESSED
- 30 Sept 2020 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 30 Jun 2020 — REGISTERED-PRINCIPAL REGISTER
- 14 Apr 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 14 Apr 2020 — PUBLISHED FOR OPPOSITION
- 25 Mar 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 09 Mar 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 20 Feb 2020 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 20 Feb 2020 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 20 Feb 2020 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 20 Feb 2020 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 20 Feb 2020 — TEAS CHANGE OF OWNER ADDRESS RECEIVED